Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2007

01-10-2007 | Research Article

Comparison of hospital pharmacy practice in France and Canada: can different practice perspectives complement each other?

Authors: Sonia Prot-Labarthe, Jean-François Bussières, Françoise Brion, Olivier Bourdon

Published in: International Journal of Clinical Pharmacy | Issue 5/2007

Login to get access

Abstract

Objective

To compare hospital pharmacy practice in France and Canada by identifying similarities and differences in the two institution’s pharmacy activities, resources, drug dispensing processes and responsibilities.

Setting

Centre hospitalier universitaire Sainte-Justine (SJ), Montréal, Québec, Canada and Hôpital Robert Debré (RD), Paris, France, are two maternal-child teaching hospitals. They share a similar mission focused on patient care, teaching and research.

Method

The data were gathered from annual reports, department strategic plans and by direct observation.

Main outcome measure

The description and comparison of the legal environment, hospital demographics, pharmacy department data, drug dispensing processes and pharmacist activities in the two institutions.

Results

The Centre hospitalier universitaire Sainte-Justine and Hôpital Robert Debré are similar with respect to their mission and general demographics; number of beds, annual hospital expenditures, number of admissions, visits and childbirths. The respective pharmacy departments differ in allocated resources. The main operational differences concern compounding, quality control programs and clinical activities. The French department also manages medical devices, medical gases, blood derivatives and the sterilisation unit. These comparisons highlight the more patient-oriented Canadian hospital pharmacy practice against the more product-oriented French hospital practice Factors contributing to these differences include academic curriculum, the attention paid to the legal environment by professional bodies, staffing patterns and culture.

Conclusion

There are differences between the hospital pharmacy practice in the studied hospitals in Canada and France. Hospital pharmacy practice in France seems to be more product oriented, and the practice in Canada seems more patient oriented.
Literature
1.
go back to reference LeBlanc JM, Dasta JF (2005) Scope of international hospital pharmacy practice. Ann Pharmacother 39(1):183–191PubMed LeBlanc JM, Dasta JF (2005) Scope of international hospital pharmacy practice. Ann Pharmacother 39(1):183–191PubMed
3.
go back to reference Thielke T, Nabeshina T, Hasegawa M (2002) Hospital pharmacy practice. Int Pharm J 16(1):1–40 Thielke T, Nabeshina T, Hasegawa M (2002) Hospital pharmacy practice. Int Pharm J 16(1):1–40
4.
go back to reference Bussières J, Roy P, Lebel D, Binette M, Cambar J, Colombel C. (2002) Pratique pharmaceutique en France et au Québec: perspectives d’échanges? [Pharmaceutical practice in France and Quebec: profile of interships?]. J Pharm Clin 21:9–13 Bussières J, Roy P, Lebel D, Binette M, Cambar J, Colombel C. (2002) Pratique pharmaceutique en France et au Québec: perspectives d’échanges? [Pharmaceutical practice in France and Quebec: profile of interships?]. J Pharm Clin 21:9–13
5.
go back to reference Bussieres J, Benabdessadok N, Roy H, Veyre M, Thiry-Alquier F (2004) Étude descriptive et comparative du circuit du médicament dans un établissement de santé français et un établissement québécois. A descriptive and comparative study of drug distribution systems in a French hospital and in a Quebec hospital. Le Pharmacien Hospitalier 39(157):67–75 Bussieres J, Benabdessadok N, Roy H, Veyre M, Thiry-Alquier F (2004) Étude descriptive et comparative du circuit du médicament dans un établissement de santé français et un établissement québécois. A descriptive and comparative study of drug distribution systems in a French hospital and in a Quebec hospital. Le Pharmacien Hospitalier 39(157):67–75
6.
go back to reference McKerrow R, Johnson N, Hall K, Harding J, Bussières J, Lefebvre P, et al. 2001/2002 Annual Report: Hospital Pharmacy in Canada Survey. [cited 28th december 2005]; Available from: www.lillyhospitalsurvey.ca McKerrow R, Johnson N, Hall K, Harding J, Bussières J, Lefebvre P, et al. 2001/2002 Annual Report: Hospital Pharmacy in Canada Survey. [cited 28th december 2005]; Available from: www.lillyhospitalsurvey.ca
7.
9.
go back to reference Arrêté du 31 mars 1999 relatif à la prescription, à la dispensation et à l’administration des médicaments soumis à la réglementation des substances vénéneuses dans les établissements de santé, les syndicats interhospitaliers et les établissements médico-sociaux disposant d’une pharmacie à usage intérieur mentionnés à l’article L. 595–1 du code de la santé publique [Bill 31st march 1999 related to Hospital Pharmacy drug use process (prescription, delivering and administration)]. In: Santé Publique; 1999 Arrêté du 31 mars 1999 relatif à la prescription, à la dispensation et à l’administration des médicaments soumis à la réglementation des substances vénéneuses dans les établissements de santé, les syndicats interhospitaliers et les établissements médico-sociaux disposant d’une pharmacie à usage intérieur mentionnés à l’article L. 595–1 du code de la santé publique [Bill 31st march 1999 related to Hospital Pharmacy drug use process (prescription, delivering and administration)]. In: Santé Publique; 1999
10.
go back to reference Décret n° 2000–1316 du 26 décembre 2000 relatif aux pharmacies à usage intérieur et modifiant le code de la santé publique—deuxième partie: Décrets en Conseil d’Etat [Bill n° 2000–1316 26th December 2000 related to hospital pharmacy and modifying public health policy code. Second Part]. In: Santé Publique; 2000 Décret n° 2000–1316 du 26 décembre 2000 relatif aux pharmacies à usage intérieur et modifiant le code de la santé publique—deuxième partie: Décrets en Conseil d’Etat [Bill n° 2000–1316 26th December 2000 related to hospital pharmacy and modifying public health policy code. Second Part]. In: Santé Publique; 2000
16.
go back to reference Dekhtawala KN, Patel MS, Engle JP (1996) Pharmacy education and practice in France. Am J Health Syst Pharm 53(13):1600–1602PubMed Dekhtawala KN, Patel MS, Engle JP (1996) Pharmacy education and practice in France. Am J Health Syst Pharm 53(13):1600–1602PubMed
19.
go back to reference Health Canada. Health Products and Food protection branch. Policy on manufacturing and compounding drug products in Canada POL-0051. Draft Health Canada. Health Products and Food protection branch. Policy on manufacturing and compounding drug products in Canada POL-0051. Draft
20.
go back to reference Canales PL, Dorson PG, Crismon ML (2001) Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health Syst Pharm 58(14):1309–1316PubMed Canales PL, Dorson PG, Crismon ML (2001) Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health Syst Pharm 58(14):1309–1316PubMed
21.
go back to reference Gattis WA, Hasselblad V, Whellan DJ, O’Connor CM (1999) Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med 159(16):1939–1945PubMedCrossRef Gattis WA, Hasselblad V, Whellan DJ, O’Connor CM (1999) Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med 159(16):1939–1945PubMedCrossRef
22.
go back to reference Kane SL, Weber RJ, Dasta JF (2003) The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med 29(5):691–698PubMed Kane SL, Weber RJ, Dasta JF (2003) The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med 29(5):691–698PubMed
23.
go back to reference Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M (1999) Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy 19(7):860–869PubMedCrossRef Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M (1999) Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy 19(7):860–869PubMedCrossRef
24.
go back to reference Bond CA, Raehl CL, Franke T (2002) Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy 22(2):134–147PubMedCrossRef Bond CA, Raehl CL, Franke T (2002) Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy 22(2):134–147PubMedCrossRef
25.
go back to reference Folli HL, Poole RL, Benitz WE, Russo JC (1987) Medication error prevention by clinical pharmacists in two children’s hospitals. Pediatrics 79(5):718–722PubMed Folli HL, Poole RL, Benitz WE, Russo JC (1987) Medication error prevention by clinical pharmacists in two children’s hospitals. Pediatrics 79(5):718–722PubMed
26.
go back to reference Bjornson DC, Hiner WO Jr., Potyk RP, Nelson BA, Lombardo FA, Morton TA et al (1993) Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 50(9):1875–1884PubMed Bjornson DC, Hiner WO Jr., Potyk RP, Nelson BA, Lombardo FA, Morton TA et al (1993) Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 50(9):1875–1884PubMed
27.
go back to reference McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA et al (1999) A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 159(19):2306–2309PubMedCrossRef McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA et al (1999) A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 159(19):2306–2309PubMedCrossRef
28.
go back to reference Bond CA, Raehl CL, Franke T (2000) Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy 20(6):609–621PubMedCrossRef Bond CA, Raehl CL, Franke T (2000) Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy 20(6):609–621PubMedCrossRef
29.
go back to reference Krupicka MI, Bratton SL, Sonnenthal K, Goldstein B (2002) Impact of a pediatric clinical pharmacist in the pediatric intensive care unit. Crit Care Med 30(4):919–921PubMedCrossRef Krupicka MI, Bratton SL, Sonnenthal K, Goldstein B (2002) Impact of a pediatric clinical pharmacist in the pediatric intensive care unit. Crit Care Med 30(4):919–921PubMedCrossRef
30.
go back to reference Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL (2003) Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy 23(1):113–132PubMedCrossRef Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL (2003) Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy 23(1):113–132PubMedCrossRef
31.
go back to reference Prot-Labarthe S, Lavoie A, Bourdon O, Lebel D, Bussières J, Faye A et al (2007) Étude pilote sur la mise en place des soins pharmaceutiques dans le service de pédiatrie générale d’un hôpital français. Collaboration et comparaison franco-québécoise. Arch Pediatr accepted for publication doi: 10.1016/j.arcped.2006.12.003. Prot-Labarthe S, Lavoie A, Bourdon O, Lebel D, Bussières J, Faye A et al (2007) Étude pilote sur la mise en place des soins pharmaceutiques dans le service de pédiatrie générale d’un hôpital français. Collaboration et comparaison franco-québécoise. Arch Pediatr accepted for publication doi: 10.​1016/​j.​arcped.​2006.​12.​003.
Metadata
Title
Comparison of hospital pharmacy practice in France and Canada: can different practice perspectives complement each other?
Authors
Sonia Prot-Labarthe
Jean-François Bussières
Françoise Brion
Olivier Bourdon
Publication date
01-10-2007
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2007
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-007-9094-2

Other articles of this Issue 5/2007

International Journal of Clinical Pharmacy 5/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine